Fierce Healthcare

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to ...
MobiHealthNews

FDA clears Adherium's third inhaler sensor, for AstraZeneca's Symbicort inhaler

Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device ...
Monthly Prescribing Reference

Digital Health Tool Propeller Cleared for Use With Symbicort Inhaler

The Food and Drug Administration (FDA) has cleared the Propeller Health digital platform to connect with the Symbicort® Inhaler (budesonide, formoterol fumarate dihydrate; AstraZeneca), a ...
MobiHealthNews

Adherium receives OTC clearance for AstraZeneca's Symbicort inhaler

Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...
FierceBiotech

AstraZeneca spins up new partnership with Propeller Health to add smart features to its Symbicort inhaler

With a new clearance from the FDA, smart inhaler developer Propeller Health is bringing its connected platform to AstraZeneca’s Symbicort to help digitize the treatment of asthma and chronic ...
FiercePharma

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Functio

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...
Penn Live

FDA gives approval for first generic of Symbicort inhaler for treatment of asthma, COPD

The U.S. Food and Drug Administration said yesterday that it has given approval for the first generic of the Symbicort inhaler to treat asthma and COPD. Symbicort is a combination of budesonide and ...
Fox 5 San Diego

AstraZeneca follows rival, will cap inhaler prices at $35 per month amid scrutiny

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (The Hill) — Drugmaker AstraZeneca will cap ...
FierceBiotech

Press Release: AstraZeneca Announces Symbicort Is Now Available In The U.S.

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...
Wall Street Journal

Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?

AstraZeneca’s move on Monday to cap at $35 the out-of-pocket costs that patients pay for the company’s Symbicort inhaler speaks to the political and regulatory pressure coming to bear on manufacturers ...
FiercePharma

Viatris prevails in another patent feud over AZ's blockbuster asthma med Symbicort

In the courtroom fracas over the patents on AstraZeneca’s multibillion-dollar inhaler Symbicort, Viatris and Kindeva Drug Delivery have toppled yet another intellectual property pillar. Still, ...
Healthline

Symbicort Cost and Financial Assistance

The price you pay for Symbicort may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. You may be able to lower your long-term costs by getting a ...